Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
David Peereboom, Case Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT00274833
First received: January 10, 2006
Last updated: December 5, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2012
  Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)